Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · IEX Real-Time Price · USD
19.62
+0.16 (0.82%)
Jul 1, 2022 12:07 PM EDT - Market open

Stock Price Forecast

According to 13 stock analysts, the average 12-month stock price forecast for MIRM stock is $63.75, which predicts an increase of 224.92%. The lowest target is $35.35 and the highest is $80.85. On average, analysts rate MIRM stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $35.35 $63.75 $69.36 $80.85
Change +80.17% +224.92% +253.52% +312.08%

Analyst Ratings

The average analyst rating for MIRM stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 555555
Buy 777777
Hold 111111
Sell 000000
Strong Sell 000000
Total 131313131313

Financial Forecast

Revenue This Year
70.26M
Increased by 267.11%
Revenue Next Year
154.89M
Increased by 120.46%
EPS This Year
-4.75
EPS Next Year
-3.03
Year 20192020202120222023202420252026
Revenue
--19.14M70.26M154.89M292.92M588.10M1.20B
Revenue Growth
---
267.11%
120.46%
89.12%
100.77%
104.79%
EPS
-4.58-4.09-2.77-4.75-3.030.050.020.01
EPS Growth
------
-67.93%
-67.29%
No. Analysts ---99733

Revenue Forecast

Revenue 20222023202420252026
High 87.2M 179.7M 341.9M 617.5M 1.3B
Avg 70.3M 154.9M 292.9M 588.1M 1.2B
Low 59.5M 128.2M 213.6M 570.5M 1.2B

Revenue Growth

Revenue Growth 20222023202420252026
High
9.0%
155.7%
120.8%
110.8%
113.0%
Avg
-12.1%
120.5%
89.1%
100.8%
104.8%
Low
-25.5%
82.5%
37.9%
94.7%
98.6%

EPS Forecast

EPS 20222023202420252026
High -4.22 -1.61 1.65 0.02 0.01
Avg -4.75 -3.03 0.05 0.02 0.01
Low -6.20 -3.94 -2.33 0.02 0.01

EPS Growth

EPS Growth 20222023202420252026
High - - -
-66.3%
-66.0%
Avg - - -
-67.9%
-67.3%
Low - - -
-68.9%
-68.3%